# Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

Source: https://onco.cc/trials/nct02843191/  
OnCo record `nct02843191` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Kyung Hee University Hospital at Gangdong, active but no longer recruiting.

## Summary

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy is a phase 3, randomised interventional study registered as NCT02843191 by Kyung Hee University Hospital at Gangdong, with a registry enrolment figure of 358 participants, started 2016-12-07 and due to reach its primary completion in 2023-07-15. Interventions recorded: Chemotherapy. Conditions listed: Rectal Cancer. Primary outcome: Pathologic complete response; Disease-free survival. Colorectal eligibility wording from the registry: "Histologically confirmed adenocarcinoma of mid or low rectum". Sites: South Korea. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT02843191
- Phase: 3
- Setting: KCSP Trial of CONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After NeoadjUvant Concurrent ChemoraDiothErapy: a Multicenter, Randomized Controlled Trial (KONCLUDE)
- Sponsor: Kyung Hee University Hospital at Gangdong
- Enrolled: 358

## Sources

- ClinicalTrials.gov NCT02843191: https://clinicaltrials.gov/study/NCT02843191

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct02843191.json